The human anti‐HER2 CAR‐Ms have the ability of antigen‐specific phagocytosis of HER2+ tumor cells, resulting in reduced tumor load and prolonged survival period in the murine ovarian cancer model. The gene discussed is ERBB2; the disease is ovarian carcinoma.